We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
Cap. Flow
-$715M
Cap. Flow %
-2.15%
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$34.4M
2
FRX
FOREST LABORATORIES INC
FRX
+$32.2M
3
XOM icon
ExxonMobil
XOM
+$23.9M
4
WBD icon
Warner Bros
WBD
+$15.4M
5
RTX icon
RTX Corp
RTX
+$13.7M

Sector Composition

Rank Sector Weight
1 Technology 14.81%
2 Financials 14.8%
3 Healthcare 13.73%
4 Industrials 10.72%
5 Energy 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPRX
2851
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$150K ﹤0.01%
12,820
CVO
2852
DELISTED
Cenevo, Inc.
CVO
$150K ﹤0.01%
7,589
GSOL
2853
DELISTED
Global Sources Ltd
GSOL
$150K ﹤0.01%
22,328
APAGF
2854
DELISTED
APCO OIL AND GAS INTERNATIONAL INC
APAGF
$150K ﹤0.01%
11,643
SNAK
2855
DELISTED
Inventure Foods, Inc.
SNAK
$149K ﹤0.01%
11,531
+125
+1% +$1.5K
NMRX
2856
DELISTED
Numerex Corp
NMRX
$149K ﹤0.01%
14,239
+1,900
+15% +$20.7K
ERII icon
2857
Energy Recovery
ERII
$459M
$148K ﹤0.01%
41,675
SKH
2858
DELISTED
SKILLED HEALTHCARE GROUP, INC. CLASS A COM STK
SKH
$148K ﹤0.01%
22,358
CCXI
2859
DELISTED
ChemoCentryx, Inc.
CCXI
$147K ﹤0.01%
32,663
MCBC
2860
DELISTED
Macatawa Bank Corp
MCBC
$146K ﹤0.01%
30,437
CYTK icon
2861
Cytokinetics
CYTK
$10.4B
$145K ﹤0.01%
41,230
REXI
2862
DELISTED
RESOURCE AMERICA INC CL-A
REXI
$145K ﹤0.01%
15,529
NWBO
2863
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$144K ﹤0.01%
28,720
+100
+0.3% +$615
QUIK icon
2864
QuickLogic
QUIK
$238M
$143K ﹤0.01%
3,426
+322
+10% +$16.8K
OMCC
2865
DELISTED
Old Market Capital Corp
OMCC
$143K ﹤0.01%
12,376
VCRA
2866
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$143K ﹤0.01%
17,781
GORO icon
2867
Goldgroup Mining Inc.
GORO
$164M
$142K ﹤0.01%
27,736
MXL icon
2868
MaxLinear
MXL
$6.09B
$142K ﹤0.01%
20,574
ENZ
2869
DELISTED
Enzo Biochem, Inc.
ENZ
$142K ﹤0.01%
27,490
BCOV
2870
DELISTED
Brightcove, Inc.
BCOV
$142K ﹤0.01%
25,442
RBCN
2871
DELISTED
Rubicon Technology, Inc.
RBCN
$142K ﹤0.01%
3,337
+17
+0.5% +$1.16K
ASXC
2872
DELISTED
Asensus Surgical, Inc.
ASXC
$140K ﹤0.01%
2,473
+27
+1% +$1.46K
GEG icon
2873
Great Elm Group
GEG
$74M
$139K ﹤0.01%
6,231
+550
+10% +$13.4K
ACW
2874
DELISTED
Accuride Corp
ACW
$139K ﹤0.01%
36,591
+2,800
+8% +$13.3K
EPM icon
2875
Evolution Petroleum
EPM
$129M
$138K ﹤0.01%
15,045

Similar funds

RhumbLine Advisers's Q3 2014 Portfolio in Review

As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
  • RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
  • RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
  • RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
  • RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
  • RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.